SCHEMBL22984247

SCHEMBL22984247

Cc1ccc2nc(C(F)(F)F)c(C(=O)NCc3ccc4c(c3)CC(C3CCC3)O4)n2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RXFP1 Q9HBX9 4/20 0.35
HTR2A P28223 1/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
GAA P10253 3/20 0.35
GLA P06280 2/20 0.35
HPGD P15428 2/20 0.35
KLK7 P49862 1/20 0.35
KLKB1 P03952 3/20 0.34
GPR55 Q9Y2T6 1/20 0.34
ATM Q13315 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
STAT6 P42226 1/20 0.34
HIF1A Q16665 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22984265 0.90 HTT (0.48) LMNAHTTSMN1; SMN2L3MBTL1RXFP1
SCHEMBL22984249 0.87 CYP2C9 (0.45) LMNAHTTSMN1; SMN2L3MBTL1RXFP1
SCHEMBL22984264 0.86 LMNA (0.45) LMNAHTTSMN1; SMN2L3MBTL1HTR2A
SCHEMBL22984267 0.84 HTT (0.47) LMNAHTTSMN1; SMN2L3MBTL1HTR2A
SCHEMBL22984263 0.82 ALDH1A1 (0.48) LMNAHTTSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL22984250 0.79 CYP2C9 (0.55) LMNAHTTSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL22984295 0.78 SMN1; SMN2 (0.50) LMNAHTTSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL22984293 0.77 HTT (0.52) LMNAHTTSMN1; SMN2L3MBTL1HTR2A
SCHEMBL22984363 0.77 HTT (0.42) LMNAHTTSMN1; SMN2L3MBTL1HTR2A
SCHEMBL22984266 0.75 LMNA (0.49) LMNAHTTSMN1; SMN2L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection UNIVERSITY OF NOTRE DAME DU LAC (US) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection BET1, BRD4, BRD3 LMNA 1620/4885HTT 4525/4885SMN1; SMN2 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.